bluebird bio’s Skysona Gains FDA Approval to Treat Ultra-Rare Neurological Disorder September 26, 2022
The Financing and Reimbursement of Cures in the US (FoCUS) White Paper Highlights BCS Stop Loss GT Product June 24, 2021
Gene Therapy Poses Volatility Concerns for the Self-Insured Community: An Actuarial View January 13, 2021
